Literature DB >> 17616659

Patterns of known and novel small RNAs in human cervical cancer.

Weng-Onn Lui1, Nader Pourmand, Bruce K Patterson, Andrew Fire.   

Abstract

Recent studies suggest that knowledge of differential expression of microRNAs (miRNA) in cancer may have substantial diagnostic and prognostic value. Here, we use a direct sequencing method to characterize the profiles of miRNAs and other small RNA segments for six human cervical carcinoma cell lines and five normal cervical samples. Of 166 miRNAs expressed in normal cervix and cancer cell lines, we observed significant expression variation of six miRNAs between the two groups. To further show the biological relevance of our findings, we examined the expression level of two significantly varying miRNAs in a panel of 29 matched pairs of human cervical cancer and normal cervical samples. Reduced expression of miR-143 and increased expression of miR-21 were reproducibly displayed in cancer samples, suggesting the potential value of these miRNAs as tumor markers. In addition to the known miRNAs, we found a number of novel miRNAs and an additional set of small RNAs that do not meet miRNA criteria.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17616659     DOI: 10.1158/0008-5472.CAN-06-0561

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  206 in total

1.  Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo.

Authors:  Arti B Gaur; Susan L Holbeck; Nancy H Colburn; Mark A Israel
Journal:  Neuro Oncol       Date:  2011-06       Impact factor: 12.300

2.  Identification of miR-23a as a novel microRNA normalizer for relative quantification in human uterine cervical tissues.

Authors:  Yuanming Shen; Yang Li; Feng Ye; Fenfen Wang; Xiaoyun Wan; Weiguo Lu; Xing Xie
Journal:  Exp Mol Med       Date:  2011-06-30       Impact factor: 8.718

3.  Distinct phases of siRNA synthesis in an endogenous RNAi pathway in C. elegans soma.

Authors:  Jonathan I Gent; Ayelet T Lamm; Derek M Pavelec; Jay M Maniar; Poornima Parameswaran; Li Tao; Scott Kennedy; Andrew Z Fire
Journal:  Mol Cell       Date:  2010-01-28       Impact factor: 17.970

Review 4.  Genome-wide approaches in the study of microRNA biology.

Authors:  Melissa L Wilbert; Gene W Yeo
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010-12-31

Review 5.  Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts.

Authors:  Vikrant V Sahasrabuddhe; Patricia Luhn; Nicolas Wentzensen
Journal:  Future Microbiol       Date:  2011-09       Impact factor: 3.165

6.  Prenatal arsenic exposure and the epigenome: altered microRNAs associated with innate and adaptive immune signaling in newborn cord blood.

Authors:  Julia E Rager; Kathryn A Bailey; Lisa Smeester; Sloane K Miller; Joel S Parker; Jessica E Laine; Zuzana Drobná; Jenna Currier; Christelle Douillet; Andrew F Olshan; Marisela Rubio-Andrade; Miroslav Stýblo; Gonzalo García-Vargas; Rebecca C Fry
Journal:  Environ Mol Mutagen       Date:  2013-12-10       Impact factor: 3.216

7.  Heterogeneity of microRNAs expression in cervical cancer cells: over-expression of miR-196a.

Authors:  Vanessa Villegas-Ruiz; Sergio Juárez-Méndez; Oscar A Pérez-González; Hugo Arreola; Lucero Paniagua-García; Miriam Parra-Melquiadez; Raúl Peralta-Rodríguez; Ricardo López-Romero; Alberto Monroy-García; Alejandra Mantilla-Morales; Guillermo Gómez-Gutiérrez; Edgar Román-Bassaure; Mauricio Salcedo
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

8.  Involvement of miR-143 in cisplatin resistance of gastric cancer cells via targeting IGF1R and BCL2.

Authors:  Ming Zhuang; Qin Shi; Xiuwei Zhang; Yongbin Ding; Liuqun Shan; Xia Shan; Jiaqi Qian; Xin Zhou; Zebo Huang; Wei Zhu; Yin Ding; Wenfang Cheng; Ping Liu; Yongqian Shu
Journal:  Tumour Biol       Date:  2014-12-10

9.  miR-143 is associated with proliferation and apoptosis involving ERK5 in HeLa cells.

Authors:  Fang Zheng; Jiahe Zhang; Siyu Luo; Jing Yi; Ping Wang; Quanqing Zheng; Yurong Wen
Journal:  Oncol Lett       Date:  2016-08-16       Impact factor: 2.967

10.  Epstein-Barr virus growth/latency III program alters cellular microRNA expression.

Authors:  Jennifer E Cameron; Claire Fewell; Qinyan Yin; Jane McBride; Xia Wang; Zhen Lin; Erik K Flemington
Journal:  Virology       Date:  2008-10-31       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.